Overview

The journey started with a small step that originated with the idea of increasing Alkem’s global footprint. And it eventually turned into a giant leap. For Alkem Labs, the United States is the focal point of international operations. In this stride, we have cumulatively filed more than 125 ANDAs with the US FDA. Alkem markets and sells products in the United States under its wholly-owned subsidiary, Ascend.

Other international operations include markets like LATAM, Europe, Africa, CIS, Southeast Asia, and Australia. Our products are marketed in about 50 international markets, directly through our subsidiaries and indirectly through active engagements with other organizations.

We are constantly looking forward to product in-licensing and out-licensing opportunities in several emerging markets. This helps us leverage our product portfolio and sales and marketing infrastructure.